Nasdaq FDA - Search News

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

The Motley Fool on MSN · 16h

Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?

Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 9% from a peak the stock set in November,

SchaeffersResearch.com · 2d

Biotech Stock Rises After FDA Approves Non-Opioid Painkiller

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) stock is up 6% at $465.02 at last glance, after the U.S. Food and Drug Administration (FDA) approved the biotech's new non-opioid painkiller, Journavx. In a statement to the press,

Investing.com on MSN · 3d

FDA approves Vertex's first-in-class non-opioid analgesic for acute pain

Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) Journavx (suzetrigine) 50 milligram oral tablets. This new drug is a non-opioid analgesic,

14hon MSN

Vertex Pharmaceuticals Just Won a Huge FDA Approval. Is the Biotech Stock a No-Brainer Buy?

Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...

3d

Biotech Stocks Facing FDA Decision In February 2025

February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...

9d

2 Healthcare Stocks You Can Buy Right Now Before They Surge Even Higher

Eli Lilly (NYSE: LLY) sells many products across treatment areas, from immunology to neuroscience. The company sells ...

2don MSN

GE HealthCare Technologies Inc. (GEHC): FDA-Cleared AI Ultrasound Systems for Women’s Health

We recently published a list of 10 AI News and Ratings Too Important to Miss. In this article, we are going to take a look at ...

3don MSN

Axsome gets FDA approval for Symbravo for migraine

Axsome Therapeutics (NASDAQ:AXSM) has received FDA approval for its drug Symbravo for the acute treatment of migraine with or ...

6d

Merck: FDA grants priority review to sNDA for Welireg

Merck (MRK) announced the U.S. FDA has accepted for priority review a supplemental new drug application seeking approval of Welireg, Merck’s ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results